Famotidine Augmentation in Schizophrenia: Hope or Hype?

被引：5

作者：

Andrade, Chittaranjan ^{[1
]}

机构：

[1] Natl Inst Mental Hlth & Neurosci, Dept Psychopharmacol, Bangalore 560029, Karnataka, India

来源：

关键词：

ADJUNCTIVE PHARMACOTHERAPY; CLINICAL-TRIAL; OPEN-LABEL; LAMOTRIGINE; HISTAMINE; THERAPY; RECEPTORS;

D O I：

10.4088/JCP.13f08707

中图分类号：

B849 [应用心理学];

学科分类号：

040203 ;

摘要：

[No abstract available]

引用

页码：E855 / E858

页数：4

共 25 条

[1] Abhari SAA, 2000, ANDEESHEH VA RAFTAR, V5, P10
[2] BLOCKADE OF MUSCARINIC, HISTAMINE-H1 AND HISTAMINE-H2 RECEPTORS BY ANTIDEPRESSANTS
ALVAREZ, FJ
VELASCO, A
PALOMARES, JL
[J]. PHARMACOLOGY, 1988, 37 (04) : 225 - 231
[3] ALVAREZ FJ, 1986, J PHARMACOL-PARIS, V17, P351
[4] Histamine and schizophrenia
Arrang, Jean-Michel
[J]. INTEGRATING THE NEUROBIOLOGY OF SCHIZOPHRENIA, 2007, 78 : 247 - +
[5] CLINICAL-PHARMACOLOGY OF FAMOTIDINE - A SUMMARY
CHREMOS, AN
[J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1987, 9 : 7 - 12
[6] Famotidine: A supplemental drug for the treatment of schizophrenia
Dannon, PN
Lepkifker, E
Iancu, I
Ziv, R
Horesh, N
Kotler, M
[J]. EUROPEAN PSYCHIATRY, 1997, 12 (05) : 263 - 264
[7] DEUTSCH SI, 1993, CLIN NEUROPHARMACOL, V16, P518
[8] Farzin D, 2005, IRAN J MED SCI, V30, P59
[9] Lamotrigine as add-on therapy in schizophrenia - Results of 2 placebo-controlled trials
Goff, Donald C.
Keefe, Richard
Citrome, Leslie
Davy, Katherine
Krystal, John H.
Large, Charles
Thompson, Thomas R.
Volavka, Jan
Webster, Elizabeth L.
[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (06) : 582 - 589
[10] GOODMAN WK, 1985, J CLIN PSYCHIAT, V46, P6